Filing Details
- Accession Number:
- 0001225208-17-005102
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-01 17:10:30
- Reporting Period:
- 2017-02-27
- Filing Date:
- 2017-03-01
- Accepted Time:
- 2017-03-01 17:10:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 78003 | Pfizer Inc | PFE | Pharmaceutical Preparations (2834) | 135315170 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1437590 | Mikael Dolsten | Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017 | President R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-02-27 | 31,800 | $0.00 | 172,115 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2017-02-27 | 6,655 | $34.25 | 165,460 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-02-27 | 16,400 | $34.28 | 149,060 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2017-02-27 | 16,581 | $34.28 | 132,479 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2017-02-27 | 24,668 | $34.27 | 107,811 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-02-27 | 27,523 | $34.26 | 80,288 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,516 | Indirect | By Rule 16b-3 Plan |
Footnotes
- The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
- The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).
- The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
Billionaire Hedge Funds
